Results 131 to 140 of about 32,019,221 (177)

Drug Resistance in Multiple Myeloma: Tumor-Intrinsic Mechanisms and the Bone Marrow Microenvironment. [PDF]

Cell Biochem Funct
Chen Y, Huang W, Tang M, Wang X.
europepmc   +1 more source

Anticancer effects of an XPO1 inhibitor (selinexor) with sotorasib following omeprazole preconditioning in KRAS G12C-mutant non-small cell lung cancer cells in vitro and in a mouse tumor xenograft. [PDF]

Neoplasia
González J, Cai X, Diao W, Roué G, València-Clua K, Olmo-González D, González-Cao M, Jain A, Jantus-Lewintre E, Giménez-Capitán A, Molina-Vila MA, Codony-Servat J, Cao P, Rosell R.   +13 more
europepmc   +1 more source

RNA export through the nuclear pore complex: pathways, mechanisms, and imaging strategies. [PDF]

RNA Biol
Fu D, Yu W, Zhang F, Rush C, Tingey M, Yang W.   +5 more
europepmc   +1 more source

Stay with me: rPL4 kidnaps the viral replicase to limit TVBMV infection. [PDF]

Plant Physiol
Uranga M.
europepmc   +1 more source

Versatility of the ER protein folding factory [PDF]

, 2005
van Anken, E., Cellular Protein Chemistry 1, Braakman, I., Dep Scheikunde, Eiwitvouwing en cellulaire factoren   +4 more
core  

A new therapeutic approach to <i>KRAS</i> mutant non-small cell lung cancer: the emerging role of exportin 1 inhibition. [PDF]

Transl Lung Cancer Res
von Itzstein MS, Gerber DE.
europepmc   +1 more source

Therapeutic Approaches Interfering with Nuclear Localization Signals: An Emerging Strategy for CNS-Related Diseases. [PDF]

Curr Neuropharmacol
Anyanwu M, Giannangeli M, Gianoncelli A, Ribaudo G.   +3 more
europepmc   +1 more source

The nuclear export receptor CRM1/XPO1 and its diverse cargoes. [PDF]

Trends Biochem Sci
Kehlenbach RH, Chook YM.
europepmc   +1 more source

<i>KRAS</i> under attack: recent advances in targeted therapies involving G12C inhibitors and XPO1 inhibition. [PDF]

Transl Lung Cancer Res
Falk M, Schatz S, Tiemann M, Ficker JH, Brueckl WM.   +4 more
europepmc   +1 more source